Merck releases data on new pill to help treat COVID-19
Another potential weapon in the fight against COVID-19 could soon be on the way, with drugmaker Merck releasing promising data on a new treatment for the virus.
U.S. regulators have authorized a second pill against COVID-19, an antiviral drug from Merck that may help blunt the wave of infections driven by the omicron variant.
Drugmaker Merck asked U.S. regulators Monday to authorize its pill for treating COVID-19 in what would add an entirely new and easy-to-use weapon to the world’s arsenal against the pandemic.
Another potential weapon in the fight against COVID-19 could soon be on the way, with drugmaker Merck releasing promising data on a new treatment for the virus.
Drugmaker Merck & Co. will help produce rival Johnson & Johnson’s newly approved coronavirus vaccine in an effort to expand supply more quickly.